These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7308901)

  • 21. Food safety: risk assessment methodology and decision-making criteria.
    Brock WJ; Rodricks JV; Rulis A; Dellarco VL; Gray GM; Lane RW
    Int J Toxicol; 2003; 22(6):435-51. PubMed ID: 14680991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy of long-term animal testing for quantitative evaluation of chemical carcinogenicity.
    Hayashi Y; Kurokawa Y; Maekawa A; Takahashi M
    Dev Toxicol Environ Sci; 1986; 12():383-91. PubMed ID: 3549239
    [No Abstract]   [Full Text] [Related]  

  • 23. Putting the Predictive Toxicology Challenge into perspective: reflections on the results.
    Benigni R; Giuliani A
    Bioinformatics; 2003 Jul; 19(10):1194-200. PubMed ID: 12835261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations at the interface of mutation research and regulatory policy.
    Flamm WG
    Mutat Res; 2003 Sep; 544(1):1-7. PubMed ID: 12888105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative methods of toxicity testing. Consensus document following an International Life Sciences Institute-ILSI Europe Workshop held in May 1995.
    Huggett AC; Schilter B; Roberfroid M; Antignac E; Koeman JH
    Food Chem Toxicol; 1996 Feb; 34(2):183-92. PubMed ID: 8606035
    [No Abstract]   [Full Text] [Related]  

  • 26. Interpreting the Delaney Clause in the 21st century.
    Picut CA; Parker GA
    Toxicol Pathol; 1992; 20(4):617-27, discussion 628-9. PubMed ID: 1308627
    [No Abstract]   [Full Text] [Related]  

  • 27. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
    Dieter HH; Konietzka R; Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
    [No Abstract]   [Full Text] [Related]  

  • 28. An improved procedure for low-dose carcinogenic risk assessment from animal data.
    Crump KS
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):339-48. PubMed ID: 6520736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events.
    Simon TW; Simons SS; Preston RJ; Boobis AR; Cohen SM; Doerrer NG; Fenner-Crisp PA; McMullin TS; McQueen CA; Rowlands JC;
    Crit Rev Toxicol; 2014 Aug; 44 Suppl 3():17-43. PubMed ID: 25070415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procedures for assessing risk at low levels of exposure.
    Cornfield J; Rai K; Van Ryzin J
    Arch Toxicol Suppl; 1980; 3():295-303. PubMed ID: 6930948
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk assessment of carcinogens: present status and future directions.
    Munro IC
    Biomed Environ Sci; 1988 Jun; 1(1):51-8. PubMed ID: 3077260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delaney and cancer.
    Jukes TH
    Nature; 1994 Apr; 368(6472):580. PubMed ID: 8145836
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4.8 Current schemes for decision-making in toxicology.
    Griesinger C; Hoffmann S; Kinsner A; Coecke S; Hartung T
    Hum Exp Toxicol; 2009 Feb; 28(2-3):147. PubMed ID: 19713383
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk assessment of carcinogens in food.
    Barlow S; Schlatter J
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):180-90. PubMed ID: 19909764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The calculation and use of carcinogenic potency: a review.
    Barr JT
    Regul Toxicol Pharmacol; 1985 Dec; 5(4):432-59. PubMed ID: 3912853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of toxicological endpoints by structure-activity relationships.
    Enslein K
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):131S-135S. PubMed ID: 6382350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.